INSUBCONTINENT EXCLUSIVE:
They ended 4 per cent higher at Rs 3,326.3 on Thursday
molecule growth of the acquired portfolio is low to mid-single digits, and despite initial cost synergies, we expect the acquisition to be
FY22 through internal accruals
Given the low growth rate of the portfolio, even assuming 500bps margin expansion, assuming a 12 year amortisation schedule, analysts
a healthy dividend payout of 25.92 per cent is currently trading at 3.45 times its book value
It has a low return on equity of 10.37 per cent for the past three years
intensifying competition in its products, which impacted gross margins
Ebitda margin for the acquired business, we estimate the acquired business could add earnings per share of Rs 5 without factoring in any
